Literature DB >> 19888039

Diverse placental pathologies as the main causes of fetal death.

Fleurisca J Korteweg1, Jan Jaap H M Erwich, Jozien P Holm, Joke M Ravisé, Jan van der Meer, Nic J G M Veeger, Albertus Timmer.   

Abstract

OBJECTIVE: To estimate the occurrence of placental causes of fetal death in relation to different gestational ages and their clinical manifestations during pregnancy.
METHODS: In a prospective cohort study conducted from 2002 to 2006, we studied 750 couples with singleton intrauterine fetal death after 20 weeks of gestation. Cause of death was classified according to the Dutch Tulip cause of death classification for perinatal mortality. Differences between groups for categorical data were evaluated by the Fisher exact test or chi test.
RESULTS: The main causes were placental pathology (64.9%), congenital anomaly (5.3%), infection (1.9%), other (4.8%), and unknown (23.1%). The contribution of causes differed over gestational age periods. At lower gestational age, placental and unknown were the most dominant causes of death (34.8% and 41.7%, respectively); at higher gestational age, the relative importance of an unknown cause decreased and a placental cause increased (16.5% and 77.6%) (P<.001). Placental bed pathology was observed in 33.6% of all fetal deaths, with the highest occurrence between 24 0/7 and 31 6/7 weeks and a strong decline after 32 weeks. In contrast, contribution of developmental placental pathology (17.6%) increased after 32 weeks of gestation (P<.001), as did umbilical cord complications (5.2%) and combined placental pathology (5.4%). Solitary placental parenchyma pathology was less frequent (3.1%). Hypertension-related disease was observed in 16.1% (95% confidence interval [CI] 13.6-19.0) of the cohort, small for gestational age fetuses in 37.9% (95% CI 34.1-41.7), and diabetes-related disease in 4.1% (95% CI 2.8-5.8).
CONCLUSION: Most fetal deaths were caused by a variety of placental pathologies. These were related to gestational age, and their clinical manifestations varied during pregnancy. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2009        PMID: 19888039     DOI: 10.1097/AOG.0b013e3181b72ebe

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  23 in total

1.  An imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.

Authors:  Roberto Romero; Tinnakorn Chaiworapongsa; Offer Erez; Adi L Tarca; Maria Teresa Gervasi; Juan Pedro Kusanovic; Pooja Mittal; Giovanna Ogge; Edi Vaisbuch; Shali Mazaki-Tovi; Zhong Dong; Sun Kwon Kim; Lami Yeo; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2010-05-12

2.  Causes of death among stillbirths.

Authors: 
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

3.  The prediction of fetal death with a simple maternal blood test at 20-24 weeks: a role for angiogenic index-1 (PlGF/sVEGFR-1 ratio).

Authors:  Tinnakorn Chaiworapongsa; Roberto Romero; Offer Erez; Adi L Tarca; Agustin Conde-Agudelo; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo; Steven J Korzeniewski
Journal:  Am J Obstet Gynecol       Date:  2017-10-13       Impact factor: 8.661

4.  Association of coexisting morphological umbilical cord abnormality and clinical cord compromise with hypoxic and thrombotic placental histology.

Authors:  Jerzy Stanek
Journal:  Virchows Arch       Date:  2016-03-16       Impact factor: 4.064

5.  Placental physiology monitored by hyperpolarized dynamic 13C magnetic resonance.

Authors:  Stefan Markovic; Anne Fages; Tangi Roussel; Ron Hadas; Alexander Brandis; Michal Neeman; Lucio Frydman
Journal:  Proc Natl Acad Sci U S A       Date:  2018-02-14       Impact factor: 11.205

6.  Maternal plasma angiogenic index-1 (placental growth factor/soluble vascular endothelial growth factor receptor-1) is a biomarker for the burden of placental lesions consistent with uteroplacental underperfusion: a longitudinal case-cohort study.

Authors:  Steven J Korzeniewski; Roberto Romero; Tinnakorn Chaiworapongsa; Piya Chaemsaithong; Chong Jai Kim; Yeon Mee Kim; Jung-Sun Kim; Bo Hyun Yoon; Sonia S Hassan; Lami Yeo
Journal:  Am J Obstet Gynecol       Date:  2015-12-11       Impact factor: 8.661

7.  Fetal death: an extreme manifestation of maternal anti-fetal rejection.

Authors:  Kia Lannaman; Roberto Romero; Tinnakorn Chaiworapongsa; Yeon Mee Kim; Steven J Korzeniewski; Eli Maymon; Nardhy Gomez-Lopez; Bogdan Panaitescu; Sonia S Hassan; Lami Yeo; Bo Hyun Yoon; Chong Jai Kim; Offer Erez
Journal:  J Perinat Med       Date:  2017-10-26       Impact factor: 1.901

8.  Post-mortem magnetic resonance foetal imaging: a study of morphological correlation with conventional autopsy and histopathological findings.

Authors:  Annamaria Vullo; Valeria Panebianco; Giuseppe Cannavale; Mariarosaria Aromatario; Luigi Cipolloni; Paola Frati; Alessandro Santurro; Francesco Vullo; Carlo Catalano; Vittorio Fineschi
Journal:  Radiol Med       Date:  2016-07-27       Impact factor: 3.469

9.  Stillbirth, Inflammatory Markers, and Obesity: Results from the Stillbirth Collaborative Research Network.

Authors:  Margo S Harrison; Vanessa R Thorsten; Donald J Dudley; Corette B Parker; Matthew A Koch; Carol J R Hogue; Barbara J Stoll; Robert M Silver; Michael W Varner; M Halit Pinar; Donald R Coustan; George R Saade; Radek K Bukowski; Deborah L Conway; Marian Willinger; Uma M Reddy; Robert L Goldenberg
Journal:  Am J Perinatol       Date:  2018-04-02       Impact factor: 1.862

10.  [Evaluation of intrauterine death: importance of examination of fetal, placental and maternal factors].

Authors:  L Freitag; C von Kaisenberg; H H Kreipe; K Hussein
Journal:  Pathologe       Date:  2014-02       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.